Technical Analysis for CBIO - Catalyst Inc.

Grade Last Price % Change Price Change
grade D 25.25 -1.90% -0.49
CBIO closed down 1.9 percent on Friday, June 15, 2018, on 1.97 times normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical CBIO trend table...

Date Alert Name Type % Chg
Jun 14 50 DMA Resistance Bearish -1.90%
Jun 14 Up 3 Days in a Row Strength -1.90%
Jun 13 MACD Bullish Signal Line Cross Bullish 1.24%
Jun 12 Stochastic Buy Signal Bullish 4.82%
Jun 12 Oversold Stochastic Weakness 4.82%
Jun 11 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 7.91%
Jun 11 Outside Day Range Expansion 7.91%
Jun 11 Oversold Stochastic Weakness 7.91%
Jun 8 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 5.38%
Jun 8 Narrow Range Bar Range Contraction 5.38%

Older signals for CBIO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Catalyst Biosciences, Inc., a biopharmaceutical company, focuses on discovering and developing novel biopharmaceutical products based on engineered human proteases. The company designs its proteases to promote hemostasis and to prevent inflammation. Its pipeline of protease therapeutics include CB 813d/PF-05280602, an engineered Factor VIIa drug candidate that completed a Phase 1 clinical trial evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity. The company's pre-clinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of hemophilia B inhibitor patients; and an engineered Factor Xa for hemophilia and the control of bleeding in non-hemophilia patients. It also develops factor C3 for the prevention of renal delayed graft function and the treatment of dry age-related macular degeneration. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.
Is CBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.0
52 Week Low 3.11
Average Volume 178,141
200-Day Moving Average 17.1166
50-Day Moving Average 25.852
20-Day Moving Average 24.6905
10-Day Moving Average 24.443
Average True Range 1.5583
ADX 9.76
+DI 18.52
-DI 17.0
Chandelier Exit (Long, 3 ATRs ) 25.2751
Chandelier Exit (Short, 3 ATRs ) 27.5349
Upper Bollinger Band 27.0431
Lower Bollinger Band 22.3379
Percent B (%b) 0.62
BandWidth 19.056722
MACD Line -0.38
MACD Signal Line -0.5678
MACD Histogram 0.1879
Fundamentals Value
Market Cap 108.81 Million
Num Shares 4.31 Million
EPS -14.07
Price-to-Earnings (P/E) Ratio -1.79
Price-to-Sales 35.66
Price-to-Book 0.66
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.56
Resistance 3 (R3) 27.50 26.68 27.18
Resistance 2 (R2) 26.68 26.09 26.71 27.05
Resistance 1 (R1) 25.96 25.72 25.55 26.02 26.92
Pivot Point 25.14 25.14 24.93 25.17 25.14
Support 1 (S1) 24.42 24.55 24.01 24.48 23.58
Support 2 (S2) 23.60 24.18 23.63 23.45
Support 3 (S3) 22.88 23.60 23.33
Support 4 (S4) 22.94